Isolated hyperthermic perfusions for cutaneous melanoma in-transit metastasis of the limb and uveal melanoma metastasis to the liver

被引：8
作者：
Huibers, Anne [1 ,2 ]
Depalo, Danielle K. [3 ]
Perez, Matthew C. [3 ]
Zager, Jonathan S. [3 ,4 ]
Olofsson Bagge, Roger [1 ,2 ]
机构：
[1] Sahlgrens Univ Hosp, Dept Radiol, S-41345 Gothenburg, Sweden
[2] Univ Gothenburg, Sahlgrenska Acad, Inst Clin Sci Obstet & Gynecol, S-41390 Gothenburg, Sweden
[3] H Lee Moffitt Canc Ctr & Res Inst, Dept Cutaneous Oncol, Tampa, FL USA
[4] Univ South Florida Hlth, Morsani Coll Med, Dept Oncol Sci, Tampa, FL USA
来源：
CLINICAL & EXPERIMENTAL METASTASIS | 2024年 / 41卷 / 04期
关键词：
In transit metastasis; Uveal melanoma; Isolated limb perfusion; Isolated limb infusion; Isolated hepatic perfusion; Percutaneous hepatic perfusion; TERM-FOLLOW-UP; MALIGNANT-MELANOMA; OCULAR MELANOMA; CHOROIDAL MELANOMA; INFUSION; CHEMOTHERAPY; PROGRESSION; MELPHALAN; CANCER; PROGNOSIS;
D O I：
10.1007/s10585-023-10234-6
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
Patients with cutaneous melanoma can develop in-transit metastases (ITM), most often localized to limbs. For patients with uveal melanoma that develop metastatic disease, the overall majority develop isolated liver metastases. For these types of metastases, regional cancer therapies have evolved as effective treatments. Isolated limb perfusion (ILP), isolated limb infusion (ILI), isolated hepatic perfusion (IHP) and percutaneous hepatic perfusion (PHP) achieve a high local concentration of chemotherapy with minimal systemic exposure. This review discusses the mechanism and available literature on locoregional treatment modalities in the era of modern immunotherapy.
引用
收藏
页码：447 / 456
页数：10
相关论文
共 92 条
  • [71] Long-term follow-up of 163 consecutive patients treated with isolated limb perfusion for in-transit metastases of malignant melanoma
    Olofsson, Roger
    Mattsson, Jan
    Lindner, Per
    [J]. INTERNATIONAL JOURNAL OF HYPERTHERMIA, 2013, 29 (06) : 551 - 557
  • [72] Predictors and natural history of in-transit melanoma after sentinel lymphadenectomy
    Pawlik, TM
    Ross, MI
    Johnson, MM
    Schacherer, CW
    McClain, DM
    Mansfield, PF
    Lee, JE
    Cormier, JN
    Gershenwald, JE
    [J]. ANNALS OF SURGICAL ONCOLOGY, 2005, 12 (08) : 587 - 596
  • [73] Nivolumab and Ipilimumab in Metastatic Uveal Melanoma: Results From a Single-Arm Phase II Study
    Pelster, Meredith S.
    Gruschkus, Stephen K.
    Bassett, Roland
    Gombos, Dan S.
    Shephard, Michael
    Posada, Liberty
    Glover, Maura S.
    Simien, Rinata
    Diab, Adi
    Hwu, Patrick
    Carter, Brett W.
    Patel, Sapna P.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2021, 39 (06) : 599 - +
  • [74] Phase I study of hepatic arterial melphalan infusion and hepatic venous hemofiltration using percutaneously placed catheters in patients with unresectable hepatic malignancies
    Pingpank, JF
    Libutti, SK
    Chang, R
    Wood, BJ
    Neeman, Z
    Kam, AW
    Figg, WD
    Zhai, SP
    Beresneva, T
    Seidel, GD
    Alexander, HR
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (15) : 3465 - 3474
  • [75] Colorectal cancer-derived small extracellular vesicles induce TGFβ1-mediated epithelial to mesenchymal transition of hepatocytes
    Pucci, Marzia
    Moschetti, Marta
    Urzi, Ornella
    Loria, Marco
    Conigliaro, Alice
    Di Bella, Maria Antonietta
    Crescitelli, Rossella
    Bagge, Roger Olofsson
    Gallo, Alessia
    Santos, Mark F.
    Puglisi, Caterina
    Forte, Stefano
    Lorico, Aurelio
    Alessandro, Riccardo
    Fontana, Simona
    [J]. CANCER CELL INTERNATIONAL, 2023, 23 (01)
  • [76] Current Trends in Regional Therapy for Melanoma: Lessons Learned from 225 Regional Chemotherapy Treatments between 1995 and 2010 at a Single Institution
    Raymond, Amanda K.
    Beasley, Georgia M.
    Broadwater, Gloria
    Augustine, Christina K.
    Padussis, James C.
    Turley, Ryan
    Peterson, Bercedis
    Seigler, Hilliard
    Pruitt, Scott K.
    Tyler, Douglas S.
    [J]. JOURNAL OF THE AMERICAN COLLEGE OF SURGEONS, 2011, 213 (02) : 306 - 316
  • [77] Read RL, 2015, ANN SURG ONCOL, V22, P475, DOI 10.1245/s10434-014-4100-0
  • [78] Pembrolizumab versus ipilimumab in advanced melanoma (KEYNOTE-006): post-hoc 5-year results from an open-label, multicentre, randomised, controlled, phase 3 study
    Robert, Caroline
    Ribas, Antoni
    Schachter, Jacob
    Arance, Ana
    Grob, Jean-Jacques
    Mortier, Laurent
    Daud, Adil
    Carlino, Matteo S.
    McNeil, Catriona M.
    Lotem, Michal
    Larkin, James M. G.
    Lorigan, Paul
    Neyns, Bart
    Blank, Christian U.
    Petrella, Teresa M.
    Hamid, Omid
    Su, Shu-Chih
    Krepler, Clemens
    Ibrahim, Nageatte
    Long, Georgina, V
    [J]. LANCET ONCOLOGY, 2019, 20 (09) : 1239 - 1251
  • [79] Predictive Factors of Regional Toxicity and Serum Creatine Phosphokinase Levels After Isolated Limb Infusion for Melanoma: A Multi-Institutional Analysis
    Santillan, Alfredo A.
    Delman, Keith A.
    Beasley, Georgia M.
    Mosca, Paul J.
    Hochwald, Steven N.
    Grobmyer, Stephen R.
    Andtbacka, Robert H.
    Noyes, R. Dirk
    Kane, John M.
    Ross, Merrick I.
    Tyler, Douglas S.
    Zager, Jonathan S.
    [J]. ANNALS OF SURGICAL ONCOLOGY, 2009, 16 (09) : 2570 - 2578
  • [80] A randomized phase II trial of gemcitabine plus treosulfan versus treosulfan alone in patients with metastatic uveal melanoma
    Schmittel, A.
    Schmidt-Hieber, M.
    Martus, P.
    Bechrakis, N. E.
    Schuster, R.
    Siehl, J. M.
    Foerster, M. H.
    Thiel, E.
    Keilholz, U.
    [J]. ANNALS OF ONCOLOGY, 2006, 17 (12) : 1826 - 1829
12345678910